Security
Cosmos Health Inc. Common Stock · COSM
COSMNASDAQCommon stockCurrentCIK 1474167Updated Oct 12, 2026
Name history
Cosmos Holdings Inc. · through Dec 19, 2022PRIME ESTATES & DEVELOPMENTS INC · through Jan 3, 2014
COSM price & chart
Loading TradingView…
NASDAQ:COSM on TradingView ↗About the company
Cosmos Health Inc. (NASDAQ: COSM), incorporated in 2009 in Nevada, is a diversified, vertically integrated global healthcare group. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life®, Mediterranation®, bio-bebe®, C-Sept® and C-Scrub®. Through its subsidiary Cana Laboratories S.A., licensed under European Good Manufacturing Practices (GMP) and certified by the European Medicines Agency (EMA), it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. Cosmos Health also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and OTC medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the UK. Furthermore, the Company has established R&D partnerships targeting major health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of novel patented nutraceuticals, specialized root extracts, proprietary complex generics, and innovative OTC products. Cosmos Health has also entered the telehealth space t…
In the news
Cosmos Health Builds Contract Manufacturing Orderbook to Over 25 Million Units; Division Positioned to Generate Over $10 Million in Recurring Annual Profit ↗
Recent filings
Results of Operations and Financial Condition
Items 2.02, 9.01
Results of Operations and Financial Condition
Items 2.02, 9.01
10-Q filing
NT 10-Q filing
RW filing
Show 5 more recent filings
S-8 filing
Material Modification to Rights of Security Holders · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Submission of Matters to a Vote of Security Holders
Items 3.03, 5.02, 5.03, 5.07, 9.01
Regulation FD Disclosure · Other Events
Items 7.01, 8.01, 9.01
4 filing
4 filing
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 65,477,518Source | 54,311,892Source | 66,014,811Source | 68,038,621Source |
| Property, Plant and Equipment, NetUSD | 10,578,858Source | 9,689,505Source | 10,455,499Source | 1,817,025Source |
| GoodwillUSD | 49,697Source | 49,697Source | 49,697Source | 49,697Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 7,519,998Source | 7,706,837Source | 7,634,486Source | 657,217Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 715,674Source | — | — | 20,749,683Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 19,628,825Source | 13,478,263Source | 19,759,254Source | 22,761,990Source |
| Inventory, NetUSD | 5,778,142Source | 4,355,365Source | 4,789,054Source | 3,451,868Source |
| Assets, CurrentUSD | 38,388,256Source | 25,461,347Source | 36,607,780Source | 56,044,903Source |
| Prepaid Expense and Other Assets, CurrentUSD | 2,007,442Source | 1,310,388Source | 1,811,911Source | 1,967,527Source |
| Operating Lease, Right-of-Use AssetUSD | 596,779Source | 696,166Source | 1,131,552Source | 821,069Source |
| Other Assets, NoncurrentUSD | 1,539,774Source | — | — | — |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 47,052,889Source | 29,778,963Source | 29,971,783Source | 28,381,912Source |
| Commitments and ContingenciesUSD | 0Source | 0Source | 0Source | 0Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | — | — | 0Source | 372,414Source |
| Common Stock, Value, IssuedUSD | 41,154Source | 23,689Source | 15,983Source | 10,606Source |
| Additional Paid in CapitalUSD | 152,136,404Source | 141,583,625Source | 129,008,301Source | 112,205,952Source |
| Retained Earnings (Accumulated Deficit)USD | -133,167,273Source | -114,022,275Source | -91,644,233Source | -66,232,813Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 331,503Source | -2,134,931Source | -419,844Source | -1,132,635Source |
| Stockholders' Equity Attributable to ParentUSD | 18,424,629Source | 24,532,929Source | 36,043,028Source | 39,284,295Source |
| Liabilities and EquityUSD | 65,477,518Source | 54,311,892Source | 66,014,811Source | 68,038,621Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 38,271,844Source | 25,757,540Source | 24,322,470Source | 21,748,869Source |
| Operating Lease, Liability, CurrentUSD | 222,115Source | 196,718Source | 285,563Source | 167,393Source |
| Operating Lease, Liability, NoncurrentUSD | 373,473Source | 498,398Source | 844,866Source | 653,673Source |
| Other Liabilities, NoncurrentUSD | 2,555,735Source | 1,959,193Source | 1,763,845Source | 1,358,803Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | — | 221,820Source | 166,348Source | 275,547Source |
| Long-term DebtUSD | 3,775,337Source | 4,108,913Source | 4,606,227Source | 5,017,987Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -19,144,998Source | -16,183,018Source | -18,542,654Source | -63,945,285Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 1,361,064Source | 1,219,355Source | — | 103,194Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 2,312,241Source | 1,689,712Source | 577,931Source | 24,401Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 4,939,952Source | -1,367,136Source | 5,484,213Source | 3,073,366Source |
| Increase (Decrease) in InventoriesUSD | 829,975Source | -146,451Source | 890,903Source | 485,469Source |
| Deferred Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 775,052Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -8,447,614Source | -7,717,034Source | -15,635,999Source | -14,870,639Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -2,014,855Source | -798,269Source | -13,760,357Source | -21,497Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 55,675Source | 418,075Source | 1,313,195Source | 74,207Source |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | — | 0Source | 100,452Source | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 14,056,091Source | 5,046,684Source | 12,694,007Source | 35,048,288Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 3,144,788Source | -3,518,090Source | -16,916,488Source | 20,463,196Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 3,459,893Source | 315,105Source | 3,833,195Source | 20,749,683Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 947,139Source | 704,839Source | 406,885Source | 588,051Source |
| Income Taxes Paid, NetUSD | 0Source | — | — | 0Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | -448,834Source | -49,471Source | -214,139Source | 307,044Source |
| Additional Financial Items | ||||
| AmortizationUSD | — | — | 0Source | — |
| Share-based Payment Arrangement, ExpenseUSD | 194,700Source | 2,383Source | 323,957Source | — |
| Amortization of Debt Issuance CostsUSD | — | 605,865Source | — | — |
| Amortization of Intangible AssetsUSD | 925,110Source | 793,836Source | 239,841Source | 33,085Source |
| DepreciationUSD | 435,954Source | 387,036Source | 353,043Source | 70,109Source |
| Derivative, Gain (Loss) on Derivative, NetUSD | 1,525,020Source | — | — | — |
| Equity Securities, FV-NI, Gain (Loss)USD | 21,368Source | — | — | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | 339,847Source | — | — | -413,279Source |
| Foreign Currency Transaction Gain (Loss), RealizedUSD | — | -121,530Source | 198,863Source | 35,823Source |
| Gain (Loss) on Disposition of Intangible AssetsUSD | -588,916Source | — | — | — |
| Gain (Loss) on InvestmentsUSD | — | 2,470Source | 4,584Source | — |
| Gain (Loss) on Extinguishment of DebtUSD | 68,610Source | 0Source | 1,910,967Source | 1,004,124Source |
| General and Administrative ExpenseUSD | 15,619,160Source | 11,733,237Source | 19,642,005Source | 10,183,025Source |
| GoodwillUSD | 49,697Source | 49,697Source | 49,697Source | 49,697Source |
| Goodwill, Impairment LossUSD | — | 291,980Source | — | — |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | — | 775,051Source |
| Net Income (Loss) Attributable to ParentUSD | -19,144,998Source | -16,183,018Source | -18,542,654Source | -13,830,371Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | -22,378,042Source | -25,783,834Source | — |
| Nonoperating Income (Expense)USD | -2,441,394Source | -638,188Source | 3,288,563Source | -5,581,284Source |
| Operating ExpensesUSD | 24,599,179Source | 19,856,153Source | 26,180,786Source | 13,430,993Source |
| Operating Lease, ExpenseUSD | — | — | 364,968Source | 210,463Source |
| Other Nonoperating Income (Expense)USD | -233,443Source | 86,737Source | -65,867Source | -2,424,649Source |
| Payments of Financing CostsUSD | 1,830,470Source | 391,575Source | 717,888Source | 3,194,798Source |
| Proceeds from Issuance of Common StockUSD | 5,417,396Source | — | 0Source | 35,275,573Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 65,271,815Source | 54,426,402Source | 53,376,874Source | 50,347,652Source |
| Cost of RevenueUSD | 57,376,240Source | 50,115,079Source | 49,027,305Source | 44,390,695Source |
| Operating Income (Loss)USD | -16,703,604Source | -15,544,830Source | -21,831,217Source | -7,474,036Source |
| Other Nonoperating Income (Expense)USD | -233,443Source | 86,737Source | -65,867Source | -2,424,649Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -19,144,998Source | -16,183,018Source | -18,542,654Source | -13,055,320Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | — | 775,051Source |
| Net Income (Loss) Attributable to ParentUSD | -19,144,998Source | -16,183,018Source | -18,542,654Source | -13,830,371Source |
| Earnings Per Share, BasicUSD per share | -0.63Source | -1.17Source | -2.15Source | -33.16Source |
| Earnings Per Share, DilutedUSD per share | -0.63Source | -1.17Source | -2.15Source | -33.16Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 30,289,072Source | 19,147,726Source | 11,968,665Source | 1,928,172Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 30,289,072Source | — | — | 1,928,172Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 925,110Source | 793,836Source | 239,841Source | 33,085Source |
| Current Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | — |
| Depreciation, Depletion and Amortization, NonproductionUSD | 1,369,353Source | 1,249,238Source | 614,377Source | 188,890Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | 339,847Source | — | — | -413,279Source |
| Foreign Currency Transaction Gain (Loss), RealizedUSD | — | -121,530Source | 198,863Source | 35,823Source |
| Gain (Loss) on InvestmentsUSD | — | 2,470Source | 4,584Source | — |
| General and Administrative ExpenseUSD | 15,619,160Source | 11,733,237Source | 19,642,005Source | 10,183,025Source |
| Goodwill, Impairment LossUSD | — | 291,980Source | — | — |
| Gross ProfitUSD | 7,895,575Source | 4,311,323Source | 4,349,569Source | 5,956,957Source |
| Interest ExpenseUSD | 1,899,872Source | 1,012,314Source | 866,476Source | 2,345,410Source |
| Interest Income, OtherUSD | 396,413Source | 406,449Source | 662,859Source | 236,349Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | -22,378,042Source | -25,783,834Source | — |
| Nonoperating Income (Expense)USD | -2,441,394Source | -638,188Source | 3,288,563Source | -5,581,284Source |
| Operating ExpensesUSD | 24,599,179Source | 19,856,153Source | 26,180,786Source | 13,430,993Source |
| Operating Lease, ExpenseUSD | — | — | 364,968Source | 210,463Source |
| Other ExpensesUSD | — | — | — | 7,599,545Source |
| Other General and Administrative ExpenseUSD | 15,603,590Source | — | 164,859Source | — |
| Other IncomeUSD | — | 0Source | 928Source | — |
| Research and Development ExpenseUSD | 519,363Source | 533,293Source | — | — |
| Selling and Marketing ExpenseUSD | 150,240Source | 354,969Source | 1,204,636Source | 630,057Source |
Offerings
Registration 333-291390
Registration 333-290420
Registration 333-283910
Filing attachments
cosm_ex991.htm · 8-K · 2026-10-09
EXHIBIT 99.1 Cosmos Health Reports Record Preliminary Nine-Month Revenue of $54.3 Million, Up 19% Year Over Year; Delivers Record Q3 Revenue of $17.4 Million and Reaffirms 2026 Revenue Outlook of Over $90 Million Every quarter of 2026 has set a record for its period — Q1, Q2 and Q3 each exceeded the highest revenue previously reported for that quarter ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────…
Read attachment ↗cosm_ex991.htm · 8-K · 2026-08-20
EX-99.1 2 cosm_ex991.htm PRESS RELEASE cosm_ex991.htm EXHIBIT 99.1 Cosmos Health Reports Q2 2026 Results: Record Q2 and H1 Revenue of $19.0M and $36.9M, Up 29% and 30%; Q2 Adjusted Gross Profit Up 58%; Total Liabilities Reduced 13%; Stockholders' Equity Up 12%; $5M Share Repurchase Program Underway Highest Q2 and H1 revenue in Company history, reflecting strength across all core segments and reaching a new milestone with an adjusted annualized revenue run-rate exceeding $75 million Co…
Read attachment ↗cosm_ex107.htm · S-8 · 2026-07-17
EXHIBIT 107 Calculation of Filing Fee Table S-8 Cosmos Health Inc. Table 1: Newly Registered Securities Security Security Fee Calculation Rule Amount Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Type Class Title …
Read attachment ↗cosm_ex991.htm · 8-K · 2026-07-06
EX-99.1 2 cosm_ex991.htm PRESS RELEASE cosm_ex991.htm EXHIBIT 99.1 Cosmos Health Authorizes Up to $5 Million Share Repurchase Program CHICAGO, IL / GLOBE NEWSWIRE / June 30, 2026 / Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its Board of Directors has authorized a share repurchase program of up to $5 million of the Company's common stock. Cosmos Health may repurchase shares from ti…
Read attachment ↗cosm_ex991.htm · 8-K · 2026-05-22
EX-99.1 2 cosm_ex991.htm PRESS RELEASE cosm_ex991.htm EXHIBIT 99.1 Cosmos Health Reports Q1 2026 Results: Revenue Up 31% to $17.9M, New Q1 Record; Total Liabilities Reduced by $4.5M; Stockholders' Equity Up 7.6%; Cash of $2.2M; Record Momentum Continues into Q2 with U.S. Expansion Underway Record Q1 revenue of $17.9M, up 31% from $13.71 million in Q1 2025, reflecting strength across all core segments Total liabilities decreased by $4.5M, or 9.6%, driven by a substantial reduction in c…
Read attachment ↗cosm_ex991.htm · 8-K · 2026-04-16
EX-99.1 2 cosm_ex991.htm PRESS RELEASE cosm_ex991.htm EXHIBIT 99.1 Cosmos Health Reports Full Year 2025 Results: Revenue Hits All-Time Record of $65.3M, Up 20%; Gross Profit Surges 83% to $7.9M; Gross Margin Expands 418 Basis Points; Adjusted EPS Improves 82%; Cash Position Up 10x to $3.5M; Record Growth Continues Into 2026 Across All Core Segments Scaled contract manufacturing division, securing long-term agreements for over 12 million units Expanded Sky Premium Life portfolio by 60 …
Read attachment ↗